Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)

Inclusion Criteria: * Male or Female 18 - 84 years of age, inclusive, who have been diagnosed with IBD. * Willing to provide a stool sample ≤120 but ≥7 days after a surveillance colonoscopy, which was negative for cancer/dysplasia. * Written informed consent document signed and dated by the subject. Exclusion Criteria: * Any condition that in the opinion of the investigator should preclude participation in the study. * A history of aerodigestive tract cancer. * Prior colorectal resection, except ileocolic resection in Crohn's disease patients. * IBD limited only to the rectum. * Subject has participated in any clinical study within the previous 30 days wherein an investigational compound or device was, or may have been, introduced into the subject.